All lobbying filings
BALLARD PARTNERS
BALLARD PARTNERS filed a Q3 report for NOVAVAX, INC. on October 18, 2026, reporting $50,000 in lobbying income.
Lobbying for NOVAVAX, INC. · Biotechnology company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 18, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Maryland
Lobbyists on this filing
1
-
JEFF MILLER Former member of CongressPreviously held: Former Member US Congress
Government bodies contacted
3
Lobbying activity
1
Guidance navigating vaccine policy.